| p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer J Liu, D He, L Cheng, C Huang, Y Zhang, X Rao, Y Kong, C Li, Z Zhang, ... Oncogene 39 (19), 3939-3951, 2020 | 83 | 2020 |
| Microcystin-LR promotes proliferation by activating Akt/S6K1 pathway and disordering apoptosis and cell cycle associated proteins phosphorylation in HL7702 cells J Liu, H Wang, B Wang, T Chen, X Wang, P Huang, L Xu, Z Guo Toxicology letters 240 (1), 214-225, 2016 | 47 | 2016 |
| Microcystin‐LR‐Caused ROS generation involved in p38 activation and tau hyperphosphorylation in neuroendocrine (PC12) cells G Meng, J Liu, S Lin, Z Guo, L Xu Environmental toxicology 30 (3), 366-374, 2015 | 38 | 2015 |
| Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice Z Li, J Liu, J Li, Y Kong, G Sandusky, X Rao, Y Liu, J Wan, X Liu Journal of Biological Chemistry 292 (42), 17461-17472, 2017 | 36 | 2017 |
| Microcystin-LR promotes cell proliferation in the mice liver by activating Akt and p38/ERK/JNK cascades J Liu, B Wang, P Huang, H Wang, K Xu, X Wang, L Xu, Z Guo Chemosphere 163, 14-21, 2016 | 35 | 2016 |
| MCLR-induced PP2A inhibition and subsequent Rac1 inactivation and hyperphosphorylation of cytoskeleton-associated proteins are involved in cytoskeleton rearrangement in SMMC … H Wang, J Liu, S Lin, B Wang, M Xing, Z Guo, L Xu Chemosphere 112, 141-153, 2014 | 31 | 2014 |
| Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration‐resistant prostate cancer X Chen, J Liu, L Cheng, C Li, Z Zhang, Y Bai, R Wang, T Han, C Huang, ... The Prostate 80 (3), 256-266, 2020 | 27 | 2020 |
| Microcystin‐LR induces a wide variety of biochemical changes in the A549 human non‐small cell lung cancer cell line: roles for protein phosphatase 2A and its substrates H Wang, K Xu, B Wang, J Liu, X Wang, M Xing, P Huang, Z Guo, L Xu Environmental toxicology 32 (3), 1065-1078, 2017 | 25 | 2017 |
| Alterations of tau and VASP during microcystin‐LR‐induced cytoskeletal reorganization in a human liver cell line Y Sun, J Liu, P Huang, Z Guo, L Xu Environmental toxicology 30 (1), 92-100, 2015 | 25 | 2015 |
| Protein phosphatase 2a inhibition and subsequent cytoskeleton reorganization contributes to cell migration caused by microcystin‐LR in human laryngeal epithelial cells (Hep‐2) B Wang, J Liu, P Huang, K Xu, H Wang, X Wang, Z Guo, L Xu Environmental toxicology 32 (3), 890-903, 2017 | 22 | 2017 |
| Plk1-mediated phosphorylation of TSC1 enhances the efficacy of rapamycin Z Li, Y Kong, L Song, Q Luo, J Liu, C Shao, X Hou, X Liu Cancer research 78 (11), 2864-2875, 2018 | 19 | 2018 |
| Inhibition of EZH2 enhances the antitumor efficacy of metformin in prostate cancer Y Kong, Y Zhang, F Mao, Z Zhang, Z Li, R Wang, J Liu, X Liu Molecular cancer therapeutics 19 (12), 2490-2501, 2020 | 18 | 2020 |
| Microcystin‐LR disrupts insulin signaling by hyperphosphorylating insulin receptor substrate 1 and glycogen synthase J Liu, C Xu, S Zhang, H Li, K Chen, P Huang, Z Guo, L Xu Environmental toxicology 33 (1), 16-22, 2018 | 12 | 2018 |
| Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance C Li, NA Lanman, Y Kong, D He, F Mao, E Farah, Y Zhang, J Liu, C Wang, ... Journal of Biological Chemistry 295 (16), 5470-5483, 2020 | 10 | 2020 |
| Epigenetics in prostate cancer treatment K Jones, Y Zhang, Y Kong, E Farah, R Wang, C Li, X Wang, ZZ Zhang, ... Journal of translational genetics and genomics 5, 341, 2021 | 9 | 2021 |
| P44/42 MAPK signal pathway-mediated hyperphosphorylation of paxillin and redistribution of E-cadherin was involved in microcystin-LR-reduced cellular adhesion in a human liver … Y Sun, X Yu, M Li, J Liu Chemosphere 200, 594-602, 2018 | 9 | 2018 |
| Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer Z Zhang, L Cheng, Q Zhang, Y Kong, D He, K Li, M Rea, J Wang, R Wang, ... Advanced Science 8 (13), 2101458, 2021 | 7 | 2021 |
| A kinome-wide CRISPR screen identifies CK1α as a target to overcome enzalutamide resistance of prostate cancer J Liu, Y Zhao, D He, KM Jones, S Tang, DB Allison, Y Zhang, J Chen, ... Cell Reports Medicine 4 (4), 2023 | 4 | 2023 |
| Generation of dual-gRNA library for combinatorial CRISPR screening of synthetic lethal gene pairs S Tang, X Wu, J Liu, Q Zhang, X Wang, S Shao, B Gokbag, K Fan, X Liu, ... STAR protocols 3 (3), 101556, 2022 | 4 | 2022 |
| Diptoindonesin G antagonizes AR signaling and enhances the efficacy of antiandrogen therapy in prostate cancer F Mao, Y Kong, J Liu, X Rao, C Li, K Donahue, Y Zhang, K Jones, ... The Prostate 82 (8), 917-932, 2022 | 4 | 2022 |
